Market Place
Sourcing Support
Edesa Biotech’s Founder Makes Strategic Investment in the Company
31 Oct 2024 //
GLOBENEWSWIRE
Edesa Biotech Announces Upcoming Conference Schedule
21 Oct 2024 //
GLOBENEWSWIRE
Pardeep Nijhawan Updates Beneficial Ownership In Edesa Biotech
13 Sep 2024 //
GLOBENEWSWIRE
Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results
09 Aug 2024 //
GLOBENEWSWIRE
Edesa’s Paridiprubart Selected For US-Funded ARDS Platform Trial
24 Jun 2024 //
CONTRACT PHARMA
Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study
16 Mar 2023 //
ACCESSWIRE
Health Canada grants approval for Edesa Biotech’s vitiligo therapy trial
02 Feb 2023 //
CLINICAL TRIALS ARENA
Pardeep Nijhawan Acquires Beneficial Ownership of Additional Securities of Edesa
17 Nov 2022 //
GLOBENEWSWIRE
Edesa Biotech Reports Fiscal 3rd Quarter 2022 Results
12 Aug 2022 //
ACCESSWIRE
Edesa Biotech Reports Enrollment Milestone in Phase 3 ARDS Study
15 Feb 2022 //
ACCESSWIRE
Edesa Biotech to Join Ontario Bioscience Panel Discussion
26 Jan 2022 //
ACCESSWIRE
Edesa Biotech Marks Enrollment Milestone in Dermatitis Study
01 Dec 2021 //
BIOSPACE
Edesa Biotech Reports Favorable Mortality Reductions in COVID-19 Study
19 Oct 2021 //
BIOSPACE
Edesa finds a signal in severely ill Covid-19 patients
21 Sep 2021 //
EVALUATE
Edesa down 20%, paring huge gains made yesterday from COVID antibody data
21 Sep 2021 //
SEEKINGALPHA
Edesa surges 60% on positive phase 2 results of COVID antibody candidate EB05
20 Sep 2021 //
SEEKINGALPHA
Edesa Biotech Enrolls More Than 525 COVID-19 Patients Ahead of Schedule
26 Aug 2021 //
BIOSPACE
Edesa Biotech Reports Fiscal 3rd Quarter 2021 Financial Results
13 Aug 2021 //
BARRONS
Edesa Biotech Reports Favorable Review of COVID-19 Study
18 Jun 2021 //
BIOSPACE
Edesa Biotech shares jump 14% premarket after early review of COVID treatment
18 Jun 2021 //
MARKETWATCH
Edesa Biotech Reports Positive Interim Results in Dermatitis Trial
03 Jun 2021 //
BIOSPACE
Edesa Biotech Expands Rights to Anti-Inflammatory Technology
22 Mar 2021 //
BIOSPACE
Edesa Biotech Completes Enrollment for Interim Clinical Study Milestone
09 Mar 2021 //
ACCESSWIRE
Edesa Biotech to Study Its Investigational Drug as Potential Rescue Therapy
26 Jan 2021 //
ACESSWIRE
Edesa Biotech gets FDA approval for EB05 trial to treat Covid-19
20 Oct 2020 //
PHARMACEUTICAL-TECHNOLOGY
Edesa Biotech Receives Approval to Initiate COVID-19 Study in the U.S.
19 Oct 2020 //
APNEWS
Edesa Biotech Files IND Application for Phase 2/3 COVID-19 Study
30 Jul 2020 //
BIOSPACE
Edesa Biotech Receives Regulatory Approval to Initiate COVID-19 Study
15 Jun 2020 //
BIOSPACE
Edesa Biotech and Light Chain Bioscience Sign License Agreement to Develop
20 Apr 2020 //
COM
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.